V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013142 | 220019722 | 1.8 | null | Palliative (P) | 2015-11-03 | 2015-11-04 | Cytarabine Low Dose | N | null | 220029244 | CYTARABINE |
| 220013143 | 220007580 | 1.7 | 28.5 | Palliative (P) | 2015-05-26 | 2015-05-27 | null | 2 | N | 220029247 | NOT MATCHED |
| 220013144 | 220007580 | 1.65 | null | null | 2015-06-17 | 2015-06-18 | Hydroxycarbamide | 02 | N | 220029247 | HYDROXYCARBAMIDE |
| 220013145 | 220007581 | 1.58 | 64 | Disease modification (D) | 2014-10-20 | 2014-10-20 | CYTARABINE | 02 | N | 220029264 | CYTARABINE |
| 220013146 | 220007581 | null | 117 | Palliative (P) | 2012-03-29 | 2014-04-05 | Cytarabine Low Dose | N | N | 220029264 | CYTARABINE |
| 220013147 | 220007581 | 0 | null | Palliative (P) | 2017-03-11 | 2017-03-11 | Cytarabine Low Dose | 2 | N | 220029264 | CYTARABINE |
| 220013148 | 220014175 | 1.52 | 54 | Curative (C) | null | 2017-08-02 | APML Induction SR ATRA,Idarubicin | N | N | 220029269 | NOT MATCHED |
| 220013150 | 220007584 | 1.62 | null | Disease modification (D) | 2015-05-25 | 2015-06-01 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220029273 | CYTARABINE |
| 220013151 | 220007584 | null | 65.3 | Disease modification (D) | 2016-07-20 | 2016-07-21 | Hydroxycarbamide | N | N | 220029273 | HYDROXYCARBAMIDE |
| 220013152 | 220007585 | 0 | 62 | Disease modification (D) | 2016-04-22 | 2016-04-23 | CYTARABINE | N | null | 220029278 | CYTARABINE |
| 220013153 | 220007586 | null | 0 | Palliative (P) | 2016-02-29 | 2016-03-01 | Hydroxycarbamide | 02 | N | 220029279 | HYDROXYCARBAMIDE |
| 220013154 | 220007586 | 1.54 | null | Adjuvant (A) | 2013-09-17 | 2013-09-17 | Hydroxycarbamide | N | N | 220029279 | HYDROXYCARBAMIDE |
| 220013155 | 220007586 | 1.55 | 107.5 | Adjuvant (A) | 2015-01-30 | 2015-02-01 | Hydroxycarbamide | N | N | 220029279 | HYDROXYCARBAMIDE |
| 220013156 | 220007586 | 1.71 | null | Palliative (P) | 2017-08-10 | 2017-08-12 | DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 1 | N | 220029279 | NOT MATCHED |
| 220013157 | 220007589 | 1.6 | 29 | Curative (C) | 2014-06-18 | 2014-06-25 | AML MyeChild 01 Triple IT | 02 | N | 220029293 | NOT MATCHED |
| 220013158 | 220007590 | 1.52 | null | Palliative (P) | 2015-04-02 | 2015-04-07 | CYTARABINE | N | N | 220029294 | CYTARABINE |
| 220013159 | 220007590 | 0 | 8.4 | Disease modification (D) | 2017-11-09 | 2017-11-25 | Amsacrine + CYTARABINE | 02 | N | 220029294 | NOT MATCHED |
| 220013160 | 220007590 | null | 68.5 | Disease modification (D) | 2013-12-15 | 2013-12-16 | Hydroxycarbamide | 2 | N | 220029294 | HYDROXYCARBAMIDE |
| 220013161 | 220019725 | null | 63.3 | null | 2018-05-17 | 2018-05-20 | Hydroxycarbamide | null | null | 220029304 | HYDROXYCARBAMIDE |
| 220013162 | 220019725 | 1.77 | null | Palliative (P) | 2018-05-28 | 2018-05-28 | Cytarabine Low Dose | N | N | 220029304 | CYTARABINE |
| 220013163 | 220007591 | null | 36.6 | null | 2014-07-30 | 2014-07-30 | AML MyeChild 01 Triple IT | N | N | 220029309 | NOT MATCHED |
| 220013164 | 220007591 | 1.44 | 0 | Adjuvant (A) | 2015-04-28 | 2015-04-28 | Hydroxycarbamide | 99 | N | 220029309 | HYDROXYCARBAMIDE |
| 220013165 | 220019726 | null | 85.6 | Disease modification (D) | 2016-08-08 | 2016-08-26 | Hydroxycarbamide | 02 | N | 220029313 | HYDROXYCARBAMIDE |
| 220013166 | 220007592 | null | 90.1 | Palliative (P) | null | 2015-09-14 | Hydroxycarbamide | null | N | 220029319 | HYDROXYCARBAMIDE |
| 220013167 | 220007593 | null | null | Palliative (P) | 2017-02-02 | 2017-02-07 | Cytarabine Low Dose | 02 | N | 220029319 | CYTARABINE |
| 220013168 | 220007594 | 1.81 | 79 | Palliative (P) | 2018-07-03 | 2018-07-03 | Cytarabine Low Dose | N | N | 220029327 | CYTARABINE |
| 220013169 | 220007598 | null | 69.2 | Curative (C) | 2014-03-17 | 2014-05-28 | Amsacrine + CYTARABINE | N | null | 220029331 | NOT MATCHED |
| 220013170 | 220007599 | 1.65 | 62.2 | Disease modification (D) | 2014-08-13 | 2014-08-24 | APML Consolidation II ATRA,Idarubicin | 02 | N | 220029332 | NOT MATCHED |
| 220013171 | 220007600 | null | 66.8 | Palliative (P) | 2016-11-03 | 2016-11-08 | null | N | null | 220029334 | NOT MATCHED |
| 220013172 | 220007601 | null | null | Disease modification (D) | null | 2014-01-16 | CYTARABINE | 02 | N | 220029336 | CYTARABINE |
| 220013173 | 220007601 | null | 33 | Curative (C) | 2017-12-12 | 2017-12-15 | CLADRIBINE + CYTARABINE + MITOXANTRONE | N | null | 220029336 | NOT MATCHED |
| 220013174 | 220017736 | 1.69 | 74.199 | Adjuvant (A) | 2015-12-11 | 2015-12-11 | AML MyeChild | N | N | 220029342 | NOT MATCHED |
| 220013175 | 220017736 | 1.69 | 88.6 | Palliative (P) | 2018-05-29 | 2018-06-24 | Cytarabine Low Dose | 2 | N | 220029342 | CYTARABINE |
| 220013176 | 220017736 | 0 | 82 | Adjuvant (A) | 2016-08-12 | 2016-08-12 | Cytarabine Low Dose | null | N | 220029342 | CYTARABINE |
| 220013177 | 220007602 | 1.61 | 68.8 | Curative (C) | 2013-05-21 | 2013-07-15 | Cytarabine Low Dose | Y | N | 220029359 | CYTARABINE |
| 220013178 | 220014185 | null | null | Disease modification (D) | 2018-03-19 | 2019-03-22 | Hydroxycarbamide | 2 | Y | 220029362 | HYDROXYCARBAMIDE |
| 220013179 | 220007603 | 0.68 | null | Palliative (P) | 2013-11-11 | 2013-11-18 | ALL Ph+ve Imatinib | N | N | 220029364 | NOT MATCHED |
| 220013180 | 220007604 | 1.63 | null | Palliative (P) | 2013-03-18 | 2013-03-21 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220029364 | CYTARABINE |
| 220013181 | 220007605 | 1.57 | 109.2 | Disease modification (D) | 2014-10-30 | 2014-10-30 | Hydroxycarbamide | N | Y | 220029369 | HYDROXYCARBAMIDE |
| 220013182 | 220007605 | 1.72 | 79.9 | Palliative (P) | null | 2016-12-03 | CYTARABINE | 2 | null | 220029369 | CYTARABINE |
| 220013183 | 220017738 | 1.82 | 72.4 | Disease modification (D) | null | 2013-03-16 | CYTARABINE | N | N | 220029388 | CYTARABINE |
| 220013184 | 220017738 | 0 | 82 | Curative (C) | 2017-08-26 | 2017-08-26 | CYTARABINE | 2 | Y | 220029388 | CYTARABINE |
| 220013185 | 220007606 | null | 39.4 | Palliative (P) | 2013-02-15 | 2013-02-15 | AML MyeChild 01 FLA | N | N | 220029391 | NOT MATCHED |
| 220013186 | 220007607 | 0.81 | 0 | null | 2016-05-13 | 2016-05-18 | Hydroxycarbamide | N | N | 220029391 | HYDROXYCARBAMIDE |
| 220013187 | 220007608 | 1.71 | 15.2 | Disease modification (D) | 2018-01-04 | 2018-01-04 | AML Interim Guidelines FLA -Ida | N | N | 220029393 | NOT MATCHED |
| 220013188 | 220007608 | 1.8 | 85 | Palliative (P) | 2017-05-08 | 2017-07-01 | Hydroxycarbamide | N | N | 220029393 | HYDROXYCARBAMIDE |
| 220013189 | 220007609 | null | null | Disease modification (D) | 2013-05-20 | 2013-05-31 | Cytarabine Low Dose | 2 | N | 220029397 | CYTARABINE |
| 220013190 | 220007609 | 1.51 | 14.3 | Disease modification (D) | 2015-05-25 | 2015-05-27 | AML MyeChild 01 IT Cyt | N | N | 220029397 | NOT MATCHED |
| 220013191 | 220017741 | null | 72 | Palliative (P) | 2017-01-20 | 2017-01-28 | AML Relapsed FLA - DaunoXome | 02 | null | 220029400 | NOT MATCHED |
| 220013192 | 220017741 | 1.8 | 74 | Disease modification (D) | 2016-02-10 | 2016-02-10 | CYTARABINE | 02 | N | 220029400 | CYTARABINE |